Authors
Loading...
This report highlights challenges in biopharmaceuticals development and classification, suggesting improvements for public health outcomes.
Miroslav Radenković (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: